I am currently serving on the NIH PCa task force and also have served on a Covid and Cancer committee a few months back. At the height of the outbreak of Covid-19 in April our trusted docs at the NCCN issued a Covid-19 based guidelines for detection and treatment that in my opinion should never have been released. I know the intentions were good but in retrospect the harms will last for years. Here are those documents:
The NCCN Prostate Cancer screening guideline during Covid-19:https://www.nccn.org/covid-19/pdf/prostate_early_detection.pdf
The NCCN Prostate Cancer Treatment guideline during Covid-19:https://www.nccn.org/covid-19/pdf/nccn_pca_covid_guidelines.pdf
We acknowledge at the NCI that patients are quite habitual. You can stop their momentum on screening and treatment, but it's hard to restart. Thus at the peak, the screening of all cancers were down 80% collectively and have only come back to about
70% since. Additionally, unscientific changes to "standard of care" require known health benefits to be set aside. I just never liked the strategy but it was put in place very early and has not been fully vetted for revision. But it certainly needs to be.
A friend of mine posted this on his website. It covers more details:https://integrativeoncology-essentials.com/2020/04/routine-cancer-screening-during-the-pandemic/
In short, telemedicine is largely in use and screening does not work well in that environment. You cannot do a DRE with a mouse. (sigh)
Post Edited (Tony Crispino) : 9/11/2020 2:19:41 PM (GMT-6)